Russell Investments Group’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Sell
7,320
-813
-10% -$1.67K ﹤0.01% 3748
2025
Q4
$16.1K Hold
8,133
﹤0.01% 3687
2025
Q3
$23.7K Buy
8,133
+2,708
+50% +$6.23K ﹤0.01% 3544
2025
Q2
$9.82K Sell
5,425
-19,209
-78% -$34.2K ﹤0.01% 3340
2025
Q1
$37K Buy
24,634
+2,414
+11% +$6.09K ﹤0.01% 2971
2024
Q4
$52.4K Buy
22,220
+21,850
+5,905% +$384K ﹤0.01% 2812
2024
Q3
$10.9K Buy
370
+99
+37% +$2.28K ﹤0.01% 3062
2024
Q2
$3.35K Hold
271
﹤0.01% 3290
2024
Q1
$5.5K Hold
271
﹤0.01% 2929
2023
Q4
$6.1K Sell
271
-2
-0.7% -$42 ﹤0.01% 2887
2023
Q3
$4.54K Buy
273
+85
+45% +$1.69K ﹤0.01% 3160
2023
Q2
$4.61K Buy
+188
New +$4.53K ﹤0.01% 3124
2023
Q1
Sell
-7,295
Closed -$215K 3373
2022
Q4
$215K Hold
7,295
﹤0.01% 2553
2022
Q3
$305K Hold
7,295
﹤0.01% 2419
2022
Q2
$205K Hold
7,295
﹤0.01% 2535
2022
Q1
$270K Hold
7,295
﹤0.01% 2395
2021
Q4
$318K Sell
7,295
-152
-2% -$7.97K ﹤0.01% 2590
2021
Q3
$461K Sell
7,447
-76,499
-91% -$6.38M ﹤0.01% 2497
2021
Q2
$7.17M Buy
83,946
+50,979
+155% +$2.73M 0.01% 1122
2021
Q1
$1.48M Buy
+32,967
New +$1.3M ﹤0.01% 2049

Other funds holding FLNA

Russell Investments Group's FLNA Position: Q1 2026 in Review

Russell Investments Group reduced its Filana Therapeutics (FLNA) stake by 10% in Q1 2026, selling an estimated $1.67K and leaving 7,320 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3748.

Russell Investments Group first reported a position in FLNA in Q1 2021 and has held it in 20 quarters since. The position peaked at $7.17M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Russell Investments Group held 7,320 shares of Filana Therapeutics worth $12.4K as of Q1 2026.
  • Russell Investments Group sold 813 Filana Therapeutics shares in Q1 2026, an estimated $1.67K.
  • Filana Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3748 holding.
  • Russell Investments Group first reported a position in Filana Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • Russell Investments Group's Filana Therapeutics position peaked at $7.17M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.